Prokop ales (32 Ergebnisse)

Zustand: Good. 415 pp., hardcover, library handstamp to title page, else fine. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.…

Zustand: New. In English.

3 volumes. 23 cm. original paperback. ca 1300 pp. ills, diagrams. references. index. ISBN\'s 1573311952, 1573313432. "Annals of the New York Academy of Sciences". -(few signs of use, otherwise (very) good). 1975g.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Used. pp. 340.

Zustand: Used. pp. 340.

Zustand: New. In English.

Zustand: New. In English.

Zustand: New. In English.

Zustand: New. In English.

Zustand: New. In English.

Zustand: New. pp. 479.

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 340 | Sprache: Englisch | Produktart: Bücher | Over the past century, the majority of chemical and energy needs of our industrial society has originated from fossilized carbon sources (coal, crude oil, natural gas). Increasingly, there is a realization that utilization of the fossilized carbon sources has adverse environmental consequences in the form of increasing concentration of greenhouse gases. We are also becoming aware of the limited nature of these resources. As a result, considerable efforts are being made to produce chemicals and fuels from renewable resources such as forest products, agricultural residues and plant products. All of these systems capture solar energy and atmospheric carbon dioxide as a part of the natural carbon cycle. Serious research efforts are also underway, targeting cultivation of photosynthetic autotrophic microbes for the production of biomass and lipids. In this category, algae appears to offer the most potential for capturing solar energy and atmospheric carbon dioxide and delivering sufficient quantities of biomass/lipids that can offset the fossilized carbon utilization in a meaningful manner without impacting food output adversely. However, several advances, both technologically as well as politically, are needed before we can realize its full potential. It is also clear that a biorefinery approach must be undertaken in order to harvest renewable energy and chemicals from algae economically.This edited, multi-authored volume on Algal Biorefineries will document new advances involving algae-based technology.…

Taschenbuch. Zustand: Neu. Algal Biorefineries | Volume 1: Cultivation of Cells and Products | Rakesh Bajpai (u. a.) | Taschenbuch | xiii | Englisch | 2016 | Springer | EAN 9789402402674 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Taschenbuch. Zustand: Neu. Systems Biology | Integrative Biology and Simulation Tools | Ale¿ Prokop (u. a.) | Taschenbuch | xxxi | Englisch | 2015 | Springer | EAN 9789400794542 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Hardcover. Zustand: Brand New. 1st edition. 324 pages. 9.25x6.25x0.75 inches. In Stock.

Hardcover. Zustand: Brand New. 1st edition. 479 pages. 9.50x6.50x1.25 inches. In Stock.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - A critical review is attempted to assess the status of nanomedicine entry onto the market. The emergence of new potential therapeutic entities such as DNA and RNA fragments requires that these new 'drugs' will need to be delivered in a cell-and organelle-specific manner. Although efforts have been made over the last 50 years or so to develop such delivery technology, no effective and above all clinically approved protocol for cell-specific drug delivery in humans exists as yet. Various particles, macromolecules, liposomes and most recently 'nanomaterials' have been said to 'show promise' but none of these promises have so far been 'reduced' to human clinical practice.The focus of this volume is on cancer indication since the majority of published research relates to this application; within that, we focus on solid tumors (solid malignancies). Our aim is critically to evaluate whether nanomaterials, both non-targeted and targeted to specific cells, could be of therapeutic benefit in clinical practice. The emphasis of this volume will be on pharmacokinetics (PK) and pharmacodynamics (PD) in animal and human studies.Apart from the case of exquisitely specific antibody-based drugs, the development of target-specific drug-carrier delivery systems has not yet been broadly successful at the clinical level. It can be argued that drugs generated using the conventional means of drug development (i.e., relying on facile biodistribution and activity after (preferably) oral administration) are not suitable for a target-specific delivery and would not benefit from such delivery even when a seemingly perfect delivery system is available. Therefore, successful development of site-selective drug delivery systems will need to include not only the development of suitable carriers, but also the development of drug entities that meet the required PK/PD profile.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Algae offer potential to produce renewable chemicals and fuels using solar energy and carbon dioxide from atmosphere or in flue gases while simultaneously reducing the generation of greenhouse gases. Since these can be grown on marginal lands with micronutrients and macronutrients often present in waste streams, algae-based chemicals and fuels do not compete with foods. Still large-scale production of algae-based fuels and chemicals faces considerable technological and economical challenges and it would by necessity require a biorefinery approach wherein all the possible algal components are converted into value-added compounds. The present series on algal biorefineries represents a forum for reporting the state of the art of different technologies as well as the latest advances in this field. The volume II of this series complements the volume I in terms of the current state of the art. Different chapters in this volume address diverse issues ranging from genetically modifies algaeto new products to life-cycle analysis of algal products.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past century, the majority of chemical and energy needs of our industrial society has originated from fossilized carbon sources (coal, crude oil, natural gas). Increasingly, there is a realization that utilization of the fossilized carbon sources has adverse environmental consequences in the form of increasing concentration of greenhouse gases. We are also becoming aware of the limited nature of these resources. As a result, considerable efforts are being made to produce chemicals and fuels from renewable resources such as forest products, agricultural residues and plant products. All of these systems capture solar energy and atmospheric carbon dioxide as a part of the natural carbon cycle. Serious research efforts are also underway, targeting cultivation of photosynthetic autotrophic microbes for the production of biomass and lipids. In this category, algae appears to offer the most potential for capturing solar energy and atmospheric carbon dioxide and delivering sufficient quantities of biomass/lipids that can offset the fossilized carbon utilization in a meaningful manner without impacting food output adversely. However, several advances, both technologically as well as politically, are needed before we can realize its full potential. It is also clear that a biorefinery approach must be undertaken in order to harvest renewable energy and chemicals from algae economically.This edited, multi-authored volume on Algal Biorefineries will document new advances involving algae-based technology.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume is a continuation of Volume 1 following the previously published Editorial. More emphasis is given to novel nanocarrier designs, their characterization and function, and applications for drug discovery and treatment. A number of chapters will deal with nanofibers as a new major application within the biomedical field with a very high success rate particularly in wound healing and diabetic foot and spine injuries. A major new subdivision will deal with mathematical methods for the assembly of nanocarriers both for simulation and function.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past century, the majority of chemical and energy needs of our industrial society has originated from fossilized carbon sources (coal, crude oil, natural gas). Increasingly, there is a realization that utilization of the fossilized carbon sources has adverse environmental consequences in the form of increasing concentration of greenhouse gases. We are also becoming aware of the limited nature of these resources. As a result, considerable efforts are being made to produce chemicals and fuels from renewable resources such as forest products, agricultural residues and plant products. All of these systems capture solar energy and atmospheric carbon dioxide as a part of the natural carbon cycle. Serious research efforts are also underway, targeting cultivation of photosynthetic autotrophic microbes for the production of biomass and lipids. In this category, algae appears to offer the most potential for capturing solar energy and atmospheric carbon dioxide and delivering sufficient quantities of biomass/lipids that can offset the fossilized carbon utilization in a meaningful manner without impacting food output adversely. However, several advances, both technologically as well as politically, are needed before we can realize its full potential. It is also clear that a biorefinery approach must be undertaken in order to harvest renewable energy and chemicals from algae economically.This edited, multi-authored volume on Algal Biorefineries will document new advances involving algae-based technology.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - A critical review is attempted to assess the status of nanomedicine entry onto the market. The emergence of new potential therapeutic entities such as DNA and RNA fragments requires that these new 'drugs' will need to be delivered in a cell-and organelle-specific manner. Although efforts have been made over the last 50 years or so to develop such delivery technology, no effective and above all clinically approved protocol for cell-specific drug delivery in humans exists as yet. Various particles, macromolecules, liposomes and most recently 'nanomaterials' have been said to 'show promise' but none of these promises have so far been 'reduced' to human clinical practice.The focus of this volume is on cancer indication since the majority of published research relates to this application; within that, we focus on solid tumors (solid malignancies). Our aim is critically to evaluate whether nanomaterials, both non-targeted and targeted to specific cells, could be of therapeutic benefit in clinical practice. The emphasis of this volume will be on pharmacokinetics (PK) and pharmacodynamics (PD) in animal and human studies.Apart from the case of exquisitely specific antibody-based drugs, the development of target-specific drug-carrier delivery systems has not yet been broadly successful at the clinical level. It can be argued that drugs generated using the conventional means of drug development (i.e., relying on facile biodistribution and activity after (preferably) oral administration) are not suitable for a target-specific delivery and would not benefit from such delivery even when a seemingly perfect delivery system is available. Therefore, successful development of site-selective drug delivery systems will need to include not only the development of suitable carriers, but also the development of drug entities that meet the required PK/PD profile.…

Hardcover. Zustand: Brand New. 1st edition. 553 pages. 9.25x6.25x1.50 inches. In Stock.

Paperback. Zustand: Brand New. reprint edition. 340 pages. 9.25x6.10x0.80 inches. In Stock.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Growth in the pharmaceutical market has slowed down - almost to a standstill. One reason is that governments and other payers are cutting costs in a faltering world economy. But a more fundamental problem is the failure of major companies to discover, develop and market new drugs. Major drugs losing patent protection or being withdrawn from the market are simply not being replaced by new therapies - the pharmaceutical market model is no longer functioning effectively and most pharmaceutical companies are failing to produce the innovation needed for success. This multi-authored new book looks at a vital strategy which can bring innovation to a market in need of new ideas and new products: Systems Biology (SB). Modeling is a significant task of systems biology. SB aims to develop and use efficient algorithms, data structures, visualization and communication tools to orchestrate the integration of large quantities of biological data with the goal of computer modeling. It involves the use of computer simulations of biological systems, such as the networks of metabolites comprise signal transduction pathways and gene regulatory networks to both analyze and visualize the complex connections of these cellular processes. SB involves a series of operational protocols used for performing research, namely a cycle composed of theoretical, analytic or computational modeling to propose specific testable hypotheses about a biological system, experimental validation, and then using the newly acquired quantitative description of cells or cell processes to refine the computational model or theory.…

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 888 | Sprache: Englisch | Produktart: Bücher | This book features a special subsection of Nanomedicine, an application of nanotech­nology to achieve breakthroughs in healthcare. It exploits the improved and often novel physical, chemical and biological properties of materials only existent at the nanometer scale. As a consequence of small scale, nanosystems in most cases are efficiently uptaken by cells and appear to act at the intracellular level. Nanotechnology has the potential to improve diagnosis, treatment and follow-up of diseases, and includes targeted drug delivery and regenerative medicine; it creates new tools and methods that impact sig­nificantly upon existing conservative practices.  This volume is a collection of authoritative reviews. In the introductory section we define the field (intracellular delivery). Then, the fundamental routes of nanode­livery devices, cellular uptake, types of delivery devices, particularly in terms of localized cellular delivery, both for small drug molecules, macromolecular drugs and genes; at the academic and applied levels, are covered. The following section is dedicated to enhancing delivery via special targeting motifs followed by the introduction of different types of intracellular nanodelivery devices (e.g. a brief description of their chemistry) and ways of producing these different devices. Finally, we put special emphasis on particular disease states and on other biomedical applications, whilst diagnostic and sensing issues are also included. Intracellular delivery / therapy is a highlytopical which will stir great inter­est. Intracellular delivery enables much more efficient drug delivery since the impact (on different organelles and sites) is intracellular as the drug is not supplied externally within the blood stream. There is great potential for targeted delivery with improved localized delivery and efficacy.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Growth in the pharmaceutical market has slowed down - almost to a standstill. One reason is that governments and other payers are cutting costs in a faltering world economy. But a more fundamental problem is the failure of major companies to discover, develop and market new drugs. Major drugs losing patent protection or being withdrawn from the market are simply not being replaced by new therapies - the pharmaceutical market model is no longer functioning effectively and most pharmaceutical companies are failing to produce the innovation needed for success. This multi-authored new book looks at a vital strategy which can bring innovation to a market in need of new ideas and new products: Systems Biology (SB). Modeling is a significant task of systems biology. SB aims to develop and use efficient algorithms, data structures, visualization and communication tools to orchestrate the integration of large quantities of biological data with the goal of computer modeling. It involves the use of computer simulations of biological systems, such as the networks of metabolites comprise signal transduction pathways and gene regulatory networks to both analyze and visualize the complex connections of these cellular processes. SB involves a series of operational protocols used for performing research, namely a cycle composed of theoretical, analytic or computational modeling to propose specific testable hypotheses about a biological system, experimental validation, and then using the newly acquired quantitative description of cells or cell processes to refine the computational model or theory.…

Zustand: New. In English.

Hardcover. Zustand: Brand New. 1st edition. 886 pages. 9.45x6.46x1.57 inches. In Stock.